List of works - Matteo Simonelli

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

scientific article published on 3 January 2013

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

scientific article published on 23 September 2006

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

scientific article published on 28 June 2017

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"

scientific article published on 21 June 2018

Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.

scientific article published on 13 April 2010

Herpes infections in breast cancer patients treated with adjuvant chemotherapy

scientific article published on 01 January 2006

High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review.

scientific article published on January 2007

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

scientific article published on 29 December 2017

Imaging biomarkers in primary brain tumours

scientific article

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

scientific article published on 21 August 2016

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

scientific article

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma

scientific article published in September 2014

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

scientific article published on 03 July 2018

Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors

scientific article published on 22 February 2019

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

scientific article

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study

scientific article published on 14 September 2020

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

scientific article published on 30 June 2015

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

scientific article published on 27 November 2020

Neutrophils in Gliomas.

scientific article published on 26 October 2017

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

scientific article published on 18 July 2017

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

scientific article published in December 2016

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

scientific article published on 14 August 2020

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

scientific article

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours

scientific article published on 20 November 2012

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

scientific article published on 09 November 2012

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

scientific article

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

scientific article published on 14 December 2017

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

scientific article published on 20 April 2010

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

scientific article published on 21 September 2017

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

scientific article

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

scientific article published on 21 January 2017

Reproducibility of the WHO classification of thymomas: practical implications

scientific article published on 29 December 2012

Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.

scientific article published on 11 April 2011

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

scientific article published on 08 January 2011

Role of myeloid cells in the immunosuppressive microenvironment in gliomas

scientific article published on 19 October 2019

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study

scientific article published on 8 November 2016

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

scientific article

Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.

scientific article published on January 2015

Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review

scientific article

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.

scientific article

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

scientific article published on 20 November 2013

List of works by Matteo Simonelli

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"

Correlation of microvascular fractal dimension with positron emission tomography [(11)C]-methionine uptake in glioblastoma multiforme: preliminary findings.

Herpes infections in breast cancer patients treated with adjuvant chemotherapy

High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review.

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

Imaging biomarkers in primary brain tumours

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular Factors

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

Neuro-Oncology During the COVID-19 Outbreak: A Hopeful Perspective at the End of the Italian Crisis

Neutrophils in Gliomas.

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.

Reproducibility of the WHO classification of thymomas: practical implications

Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

Role of myeloid cells in the immunosuppressive microenvironment in gliomas

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.

Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma